- Home
- JDZG vs IGC Comparison
JDZG vs IGC Comparison
Compare JDZG & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JDZG | IGC |
|---|---|---|
| Founded | 2020 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2M | 31.2M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | JDZG | IGC |
|---|---|---|
| Price | $0.80 | $0.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 60.7K | ★ 975.0K |
| Earning Date | 04-17-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,680,742.00 | $1,106,000.00 |
| Revenue This Year | N/A | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.19 | N/A |
| 52 Week Low | $0.77 | $0.25 |
| 52 Week High | $7.92 | $0.50 |
Technical Indicators
Market Signals| Indicator | JDZG | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 26.18 | 46.99 |
| Support Level | $0.77 | $0.28 |
| Resistance Level | $0.93 | $0.31 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.64 | 36.24 |
Price Performance
Historical ComparisonAbout JDZG JIADE LIMITED
Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.